177 related articles for article (PubMed ID: 26537842)
21. Novel NDM-9 metallo-β-lactamase identified from a ST107 Klebsiella pneumoniae strain isolated in China.
Wang X; Li H; Zhao C; Chen H; Liu J; Wang Z; Wang Q; Zhang Y; He W; Zhang F; Wang H
Int J Antimicrob Agents; 2014 Jul; 44(1):90-1. PubMed ID: 24913967
[No Abstract] [Full Text] [Related]
22. Whole genome mapping of the first reported case of KPC-2-positive Klebsiella pneumoniae ST258 in Nebraska.
Fowler RC; Scharn CR; Ali MA; Cavalieri SJ; Goering RV; Hanson ND
Diagn Microbiol Infect Dis; 2014 Jul; 79(3):384-6. PubMed ID: 24813687
[TBL] [Abstract][Full Text] [Related]
23. Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing KPC-2 carbapenemase in Belgium.
Bogaerts P; Montesinos I; Rodriguez-Villalobos H; Blairon L; Deplano A; Glupczynski Y
J Antimicrob Chemother; 2010 Feb; 65(2):361-2. PubMed ID: 20008447
[No Abstract] [Full Text] [Related]
24. Emergence of nosocomial New Delhi metallo-β-lactamase-1 (NDM-1)-producing Klebsiella pneumoniae in patients admitted to a tertiary care hospital in Kuwait.
Jamal W; Rotimi VO; Albert MJ; Khodakhast F; Udo EE; Poirel L
Int J Antimicrob Agents; 2012 Feb; 39(2):183-4. PubMed ID: 22113192
[No Abstract] [Full Text] [Related]
25. New Delhi Metallo-β-Lactamase 1-Producing
Li J; Hu X; Yang L; Lin Y; Liu Y; Li P; Wang K; Qiu S; Li P; Song H
Microb Drug Resist; 2020 May; 26(5):492-496. PubMed ID: 31730396
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of imipenem for the treatment of bacteremia due to an OXA-48-producing Klebsiella pneumoniae isolate.
Maherault AC; Nordmann P; Therby A; Pangon B
Clin Infect Dis; 2012 Feb; 54(4):577-8. PubMed ID: 22157173
[No Abstract] [Full Text] [Related]
27. [Carbapenem-resistant Klebsiella pneumoniae following foreign travel].
Leverstein-van Hall MA; Stuart JC; Voets GM; Versteeg D; Roelofsen E; Fluit AC
Ned Tijdschr Geneeskd; 2010; 154():A2013. PubMed ID: 20858323
[TBL] [Abstract][Full Text] [Related]
28. Emergence of extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae in Danish hospitals; this is in part explained by spread of two CTX-M-15 clones with multilocus sequence types 15 and 16 in Zealand.
Lester CH; Olsen SS; Jakobsen L; Arpi M; Fuursted K; Hansen DS; Heltberg O; Holm A; Højbjerg T; Jensen KT; Johansen HK; Justesen US; Kemp M; Knudsen JD; Røder B; Frimodt-Møller N; Hammerum AM
Int J Antimicrob Agents; 2011 Aug; 38(2):180-2. PubMed ID: 21612893
[No Abstract] [Full Text] [Related]
29. Outbreak of NDM-1-producing Klebsiella pneumoniae causing neonatal infection in a teaching hospital in mainland China.
Zhang X; Li X; Wang M; Yue H; Li P; Liu Y; Cao W; Yao D; Liu L; Zhou X; Zheng R; Bo T
Antimicrob Agents Chemother; 2015 Jul; 59(7):4349-51. PubMed ID: 25941224
[TBL] [Abstract][Full Text] [Related]
30. Emergence of blaNDM-1 among Klebsiella pneumoniae ST15 and novel ST1031 clinical isolates in China.
Hu L; Zhong Q; Tu J; Xu Y; Qin Z; Parsons C; Zhang B; Hu X; Wang L; Yu F; Pan J
Diagn Microbiol Infect Dis; 2013 Apr; 75(4):373-6. PubMed ID: 23453788
[TBL] [Abstract][Full Text] [Related]
31. Clonal dissemination of multilocus sequence type ST15 KPC-2-producing Klebsiella pneumoniae in Bulgaria.
Markovska R; Stoeva T; Schneider I; Boyanova L; Popova V; Dacheva D; Kaneva R; Bauernfeind A; Mitev V; Mitov I
APMIS; 2015 Oct; 123(10):887-94. PubMed ID: 26303718
[TBL] [Abstract][Full Text] [Related]
32. Emergence of an autochthonous and community-acquired NDM-1-producing Klebsiella pneumoniae in Europe.
Nordmann P; Couard JP; Sansot D; Poirel L
Clin Infect Dis; 2012 Jan; 54(1):150-1. PubMed ID: 21960718
[No Abstract] [Full Text] [Related]
33. Molecular epidemiology of OXA-48-producing Klebsiella pneumoniae in France.
Liapis E; Pantel A; Robert J; Nicolas-Chanoine MH; Cavalié L; van der Mee-Marquet N; de Champs C; Aissa N; Eloy C; Blanc V; Guyeux C; Hocquet D; Lavigne JP; Bertrand X;
Clin Microbiol Infect; 2014 Dec; 20(12):O1121-3. PubMed ID: 24942039
[TBL] [Abstract][Full Text] [Related]
34. Whole Genome Sequencing of NDM-1-Producing ST11 Klebsiella pneumoniae Isolated in a Private Laboratory in Greece.
Meletis G; Chatzopoulou F; Chatzidimitriou D; Tsingerlioti F; Botziori C; Tzimagiorgis G; Skoura L
Microb Drug Resist; 2019; 25(1):80-86. PubMed ID: 29698126
[TBL] [Abstract][Full Text] [Related]
35. Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece.
Pournaras S; Protonotariou E; Voulgari E; Kristo I; Dimitroulia E; Vitti D; Tsalidou M; Maniatis AN; Tsakris A; Sofianou D
J Antimicrob Chemother; 2009 Aug; 64(2):348-52. PubMed ID: 19525514
[TBL] [Abstract][Full Text] [Related]
36. Presence of a novel variant NDM-10, of the New Delhi metallo-beta-lactamase in a Klebsiella pneumoniae isolate.
Khajuria A; Praharaj AK; Kumar M; Grover N
Indian J Med Microbiol; 2016; 34(1):121-3. PubMed ID: 26776144
[No Abstract] [Full Text] [Related]
37. A nosocomial outbreak of KPC-2-producing Klebsiella pneumoniae in a Chinese hospital: dissemination of ST11 and emergence of ST37, ST392 and ST395.
Yang J; Ye L; Guo L; Zhao Q; Chen R; Luo Y; Chen Y; Tian S; Zhao J; Shen D; Han L
Clin Microbiol Infect; 2013 Nov; 19(11):E509-15. PubMed ID: 23841705
[TBL] [Abstract][Full Text] [Related]
38. Identification and molecular characterisation of New Delhi metallo-β-lactamase-1 (NDM-1)- and NDM-6-producing Enterobacteriaceae from New Zealand hospitals.
Williamson DA; Sidjabat HE; Freeman JT; Roberts SA; Silvey A; Woodhouse R; Mowat E; Dyet K; Paterson DL; Blackmore T; Burns A; Heffernan H
Int J Antimicrob Agents; 2012 Jun; 39(6):529-33. PubMed ID: 22526013
[TBL] [Abstract][Full Text] [Related]
39. Multilocus sequence typing compared to PFGE for molecular typing of extended spectrum beta-lactamase-producing Klebsiella pneumoniae isolates.
Elhani D; Ben Slama K; Bakir L; Boudabous A; Aouni M
Ann Biol Clin (Paris); 2011; 69(6):742-4. PubMed ID: 22123581
[No Abstract] [Full Text] [Related]
40. Bloodstream infections caused by metallo-β-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes.
Mouloudi E; Protonotariou E; Zagorianou A; Iosifidis E; Karapanagiotou A; Giasnetsova T; Tsioka A; Roilides E; Sofianou D; Gritsi-Gerogianni N
Infect Control Hosp Epidemiol; 2010 Dec; 31(12):1250-6. PubMed ID: 20973725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
